Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Income from Continuing Operations (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Income from Continuing Operations for 6 consecutive years, with 29654000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 60.4% to 29654000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 95382000.0, a 4.76% decrease, with the full-year FY2025 number at 95572000.0, down 4.55% from a year prior.
  • Income from Continuing Operations was 29654000.0 for Q4 2025 at PROCEPT BioRobotics, down from 21411000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 12822000.0 in Q1 2021 to a low of 29654000.0 in Q4 2025.
  • A 5-year average of 21799550.0 and a median of 22012000.0 in 2022 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: crashed 65.75% in 2023, then skyrocketed 32.58% in 2024.
  • PROCEPT BioRobotics' Income from Continuing Operations stood at 18348000.0 in 2021, then crashed by 35.79% to 24914000.0 in 2022, then fell by 10.07% to 27424000.0 in 2023, then surged by 32.58% to 18488000.0 in 2024, then tumbled by 60.4% to 29654000.0 in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Income from Continuing Operations are 29654000.0 (Q4 2025), 21411000.0 (Q3 2025), and 19580000.0 (Q2 2025).